UNASSIGNED: OBJECT @entity1 presenting with large-territory @entity385 may develop intractable @entity2657 that puts them at risk of death unless intervention is performed. The purpose of this study was to identify predictors of outcome for @entity5663 ( @entity5663 ) in @entity385 . METHODS The authors conducted a retrospective electronic medical record review of 1624 @entity1 from 2006 to 2014. Subjects were screened for @entity5663 secondary to @entity385 involving the middle cerebral artery, internal carotid artery, or both. Ninety-five individuals were identified. Univariate and multivariate analyses were performed for an array of clinical variables in relationship to functional outcome according to the @entity2653 ( @entity2653 ). Clinical outcome was assessed at 90 days and at the latest follow-up (mean duration 16.5 months). RESULTS The mean @entity2653 score at 90 days and at the latest follow-up post- @entity5663 was 4. Good functional outcome was observed in 40% of @entity1 at 90 days and in 48% of @entity1 at the latest follow-up. The mortality rate at 90 days was 18% and at the last follow-up 20%. Univariate analysis identified a greater likelihood of poor functional outcome ( @entity2653 scores of 4-6) in @entity1 with a history of @entity64 (OR 6.54 [95% CI1.39-30.66]; p = 0.017), peak @entity601 ( @entity601 ) > 10 mm (OR 3.35 [95% CI 1.33-8.47]; p = 0.011), or a history of @entity583 (OR 8.95 [95% CI1.10-72.76]; p = 0.04). Multivariate analysis demonstrated elevated odds of poor functional outcome associated with a history of @entity64 (OR 9.14 [95% CI 1.78-47.05]; p = 0.008), @entity601 > 10 mm (OR 5.15 [95% CI 1.58-16.79; p = 0.007), a history of @entity6 (OR 5.63 [95% CI 1.52-20.88]; p = 0.01), delayed time from onset of @entity64 to @entity5663 (OR 1.32 [95% CI 1.02-1.72]; p = 0.037), and evidence of @entity384 prior to @entity5663 (OR 4.19 [95% CI 1.06-16.51]; p = 0.04). @entity1 with @entity1188 involving the dominant hemisphere had higher odds of unfavorable functional outcome at 90 days (OR 4.73 [95% CI 1.36-16.44]; p = 0.014), but at the latest follow-up, cerebral dominance was not significantly related to outcome (OR 1.63 [95% CI 0.61-4.34]; p = 0.328). CONCLUSIONS History of @entity64 , @entity6 , @entity583 , peak @entity601 > 10 mm, increasing duration from onset of @entity64 to @entity5663 , and presence of @entity384 prior to intervention are associated with a worse functional outcome.

Decompressive hemicraniectomy: predictors of functional outcome in @entity1 with XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity2653 :: ('MESH:C538175', 'Disease') :: ['mRS', 'modified Rankin Scale'] @entity2657 :: ('MESH:D001929', 'Disease') :: ['cerebral edema'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity384 :: ('MESH:D002311', 'Disease') :: ['pupillary dilation'] @entity5663 :: ('MESH:D003665', 'Disease') :: ['decompressive hemicraniectomy', 'DH'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['infarction'] @entity601 :: ('MESH:D009436', 'Disease') :: ['midline shift', 'MLS'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction'] @entity385 :: ('MESH:D002544', 'Disease') :: ['ischemic stroke', 'ischemic strokes']
@entity385 :: (MESH:D002544,Disease) :: ['ischemic stroke']
